PRISM Biotech
    IceCure Medical Requests FDA Marketing Authorization for Breast Cancer Cryoablation Technology
    New York, April 15, 2024 - PRISM MarketView - IceCure Medical Ltd. (Nasdaq: ICCM) has submitted final data to the FDA requesting marketing authorization for ProSense® as a treatment for early stage T1 invasive breast cancer with adjuvant hormone therapy. ProSense® is alr...

    15 April 2024

    read more...
    PRISM View
    Solar Innovations Shine: Maxeon’s (MAXN) Performance 7 Panels Lead the Green Revolution
    New York, April 12, 2024 - PRISM MarketView - PRISM New Energy Index company, Maxeon Solar Technologies, Ltd. (MAXN), a prominent force in solar innovation and distribution channels worldwide, has once again elevated industry standards with the introduction of its ground...

    12 April 2024

    read more...
    PRISM View
    Granite Ridge Expands Revolving Credit Facility, Adding Liquidity to Support Growth
    New York, April 12, 2024 - PRISM MarketView - Granite Ridge Resources (NYSE: GRNT) has successfully expanded its revolving credit facility, completing its semi-annual borrowing base redetermination and entry into the third amendment to the Company’s existing credit agree...

    12 April 2024

    read more...
    PRISM Biotech
    Silence Therapeutics Advances Strong Candidate for Cholesterol Control
    New York, April 12, 2024 - PRISM MarketView - Silence Therapeutics (Nasdaq: SLN) has reported additional results from its APOLLO Phase 1 study of zerlasiran (SLN360) in subjects with baseline lipoprotein(a) (Lp(a)) levels at or over 150 nmol/L. The results were published...

    12 April 2024

    read more...
    PRISM Biotech
    NeuroOne Celebrates First Implant of OneRF™ Ablation Electrode at Top-Ranked Hospital
    New York, April 12, 2024 - PRISM MarketView - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) has announced that doctors at a top-ranked US hospital have successfully performed the first implant of the company’s OneRF™ Ablation Evo® sEEG-RF electrode. NeuroOne’s...

    12 April 2024

    read more...
    PRISM View
    A Tradition Unlike Any Other… Masterful Golf Stocks to Keep Your Portfolio on Par
    New York, April 11, 2024 - PRISM MarketView - This the season for azaleas to be in bloom and Augusta to be classically attended as the 88th Masters Tournament kicks off. This tournament has become even more exciting as both the PGA and LIV players are in attendance. Whil...

    11 April 2024

    read more...
    PRISM Features
    Portfolio Looking Ruff? PRISM Purrr-worthy Stock Plays on National Pet Day
    New York, April 11, 2024 - PRISM MarketView -If you are not a pet person and it’s not allergy related, we’d like to know what UFO you’re reading this from. Because who doesn’t love a tail wag or a meow when you walk in the door? Or maybe you’re more of a fish, reptile, o...

    11 April 2024

    read more...
    PRISM View
    Natural Alternatives (NAII) Is Supplementing Its Supplement Business, Reopening Facility Due to Increase Demand
    New York, April 10, 2024 - PRISM MarketView - While many consumer names across all market caps have struggled, the PRISM Consumer Products Index company, Natural Alternatives International Inc. (NAII) has been one of the few who has recently reported positive news that i...

    10 April 2024

    read more...
    PRISM Biotech
    Neurosense to Evaluate Biological Changes in People with Neurodegenerative Disease
    New York, April 10, 2024 - PRISM MarketView - NeuroSense Therapeutics (Nasdaq: NRSN) has announced it will collaborate with Lonza (SIX: LONN), a global development and manufacturing partner to the pharma, biotech and nutrition industries, to evaluate biological changes o...

    10 April 2024

    read more...
    PRISM Biotech
    YS Biopharma Reports Positive Results in Rabies Vaccine Trial
    New York, April 10, 2024 - PRISM MarketView - Global biopharmaceutical company, YS Biopharma (Nasdaq: YS) has announced positive interim results from its ongoing Phase 3 clinical trial of a next-generation PIKA Rabies Vaccine. The vaccine utilizes YS Biopharma’s propriet...

    10 April 2024

    read more...
    35
    36
    37
    38
    39
    40
    41
    We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
    Cookie settings
    Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
    Necessary cookies
    Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
    Preferences
    Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
    Analytical cookies
    Analytical cookies help us improve our website by collecting and reporting information on its usage.
    Marketing cookies
    Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.